drugset
drugset / Trial / NCT04051684

Regional TAP Block for Bariatric Patients

NCT04051684 ↗

Phase 1/2 Completed 23 enrolled Montefiore Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI \>35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room

Timeline

Start
2013-04
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.5 % —

Indications

No indication recorded.